167 related articles for article (PubMed ID: 38229158)
41. The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
Pages M; Uro-Coste E; Colin C; Meyronet D; Gauchotte G; Maurage CA; Rousseau A; Godfraind C; Mokhtari K; Silva K; Figarella-Branger D; Varlet P; On Behalf Of The Renoclip-Loc Network
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803647
[TBL] [Abstract][Full Text] [Related]
42. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
43. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
44. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
Pickles JC; Stone TJ; Jacques TS
J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
[TBL] [Abstract][Full Text] [Related]
45. Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review.
Singh J; Sahu S; Mohan T; Mahajan S; Sharma MC; Sarkar C; Suri V
Neurooncol Pract; 2023 Dec; 10(6):518-526. PubMed ID: 38009119
[TBL] [Abstract][Full Text] [Related]
46. Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas.
Lebrun L; Bizet M; Melendez B; Alexiou B; Absil L; Van Campenhout C; D'Haene N; Rorive S; Fuks F; Decaestecker C; Salmon I
J Neuropathol Exp Neurol; 2021 Aug; 80(7):663-673. PubMed ID: 34363673
[TBL] [Abstract][Full Text] [Related]
47. Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasia.
Wu J; Gupta R; Barreto J; Doo P; Joseph NM; Lee JC; Perry A; Chang SM; Berger MS; Solomon DA
Neuro Oncol; 2021 Oct; 23(10):1798-1800. PubMed ID: 34351421
[No Abstract] [Full Text] [Related]
48. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
49. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
51. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
52. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
53. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
[TBL] [Abstract][Full Text] [Related]
54. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
55. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
56. Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classification.
Kling T; Ferreyra Vega S; Suman M; Dénes A; Lipatnikova A; Lagerström S; Olsson Bontell T; Jakola AS; Carén H
Brain Pathol; 2024 Jan; ():e13233. PubMed ID: 38168467
[TBL] [Abstract][Full Text] [Related]
57. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
58. Microarray-Based DNA Methylation Profiling: Validation Considerations for Clinical Testing.
Leung ML; Abdullaev Z; Santana-Santos L; Skaugen JM; Moore S; Ji J
J Mol Diagn; 2024 Jun; 26(6):447-455. PubMed ID: 38378079
[TBL] [Abstract][Full Text] [Related]
59. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
Lehman NL
J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
[TBL] [Abstract][Full Text] [Related]
60. Molecular diagnostics in central nervous system tumors.
Fuller CE; Perry A
Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
